Uptake/Participation Rate of Eligible, Target Women10,20,32 |
70 % of invited women |
75 % |
Referred/Abnormality Rate9,10,20,32 |
10-14 % |
5 % first round 3 % routine re-screen |
Proportion of Women Undergoing Repeat Films (i.e., repeated exams)32 |
< 3 % of total examinations |
< 2 % of total |
Cancer Detection Rates in Eligible Women9,10,20,32 |
> 5/1000 first screen > 3.5/1000 re-screen |
6/1000 first screen |
Percentage of Cancers < 1.5 cm in Diameter Detected in Eligible, Screened Women9 |
≥ 50 % |
|
Percentage of Node Negative Cancers Detected in Eligible, Screened Women9 |
≥ 70 % |
|
Proportion of Screened Women that Undergo Biopsy9,10,20 |
< 1.5 % |
Malignant to Benign Biopsy Ratio32 |
1:1 |
1.5:1 |
Positive Predictive Value of Biopsy32 |
50 % |
60 % |
Benign Biopsy Rate32 |
< 5/1000 first screen < 3.5/1000 re-screen |
< 4/1000 first screen |
Interval Cancers in Screened Women32 |
≤ 3/1000 women screened |
|